Regarding medications for achondroplasia?
Hello, doctor! I would like to ask about medications for achondroplasia.
I have seen other websites introducing "CNP protein growth factor" as a medication for patients with achondroplasia.
I would like to know if "CNP protein growth factor" is available for sale in Taiwan, and approximately how much it costs.
Thank you very much!
fairylike, 20~29 year old female. Ask Date: 2008/12/23
Dr. Hou Jiawei reply Rare Disease
CNP (C-type natriuretic peptide) growth factor was proposed in 2005 by a research team led by Professor Kazuhisa Nakao at Kyoto University, based on experiments conducted on mice, suggesting it may help individuals with achondroplasia to increase height.
This drug has not yet been introduced in the country, and it is recommended to wait for more human clinical trial data and official approval, along with physician evaluation, before considering its use for greater safety.
Reply Date: 2008/12/23
More Info
CNP (C-type natriuretic peptide) growth factor is a promising therapeutic agent for treating achondroplasia, a common form of skeletal dysplasia characterized by disproportionate short stature. Achondroplasia is caused by a mutation in the FGFR3 gene, which negatively regulates bone growth. The introduction of CNP as a treatment option is based on its ability to stimulate chondrocyte proliferation and enhance endochondral ossification, which can potentially improve growth in affected individuals.
In recent years, clinical trials have demonstrated that CNP can lead to increased growth rates in children with achondroplasia. The mechanism involves the activation of the NPR-B receptor, which subsequently stimulates the production of cyclic GMP, promoting chondrocyte activity and bone growth. This has led to a growing interest in CNP as a viable treatment option for patients with achondroplasia.
As for the availability of CNP growth factor in Taiwan, it is essential to consult local healthcare providers or specialists in pediatric endocrinology or genetics. As of my last update, CNP was still undergoing clinical trials and had not yet received widespread approval for general use in many countries, including Taiwan. However, the landscape of drug approvals can change rapidly, so it is advisable to check with local health authorities or hospitals for the most current information.
Regarding the cost of CNP growth factor, this can vary significantly based on several factors, including the healthcare system, insurance coverage, and whether the drug is available through clinical trials or has been approved for general use. If CNP becomes commercially available, pricing would likely be determined by the manufacturer and could be influenced by factors such as production costs, demand, and regulatory considerations.
In summary, while CNP growth factor shows great promise for treating achondroplasia, its availability in Taiwan and associated costs are contingent upon regulatory approvals and market dynamics. It is crucial to stay informed through healthcare professionals and relevant medical institutions to obtain the most accurate and timely information regarding treatment options for achondroplasia. If you or someone you know is affected by this condition, discussing potential treatment options with a healthcare provider who specializes in genetic disorders or pediatric endocrinology would be beneficial. They can provide guidance on the latest research, clinical trials, and available therapies tailored to individual needs.
Similar Q&A
Understanding Prader-Willi Syndrome: Growth Hormone and Treatment Options
Hello, doctor! My sister's one-year-old daughter is suspected to have Prader-Willi syndrome or Angelman syndrome. Her hands and feet are very small (around the 3rd percentile). If she is indeed diagnosed, I would like to ask: 1. Can the use of growth hormone (i.e., somatot...
Dr. Cai Wenhui reply Rare Disease
Hello Jacky: 1. Growth hormone primarily improves the body composition (such as body fat index) and motor skills of affected children, with no reports of it causing enlargement of hands and feet. 2. The currently used growth hormone is Genotropin (produced by Pfizer), and the ...[Read More] Understanding Prader-Willi Syndrome: Growth Hormone and Treatment Options
Exploring Treatment Options for Duchenne Muscular Dystrophy in Children
The child is three and a half years old and was diagnosed last year with "Duchenne Muscular Dystrophy." Are there any more aggressive treatment options available now? The pediatric neurologist prescribed "Prednisone 5mg SHIONOGI." What is this medication used ...
Dr. Xiao Huibin reply Rare Disease
Hello, according to online sources, Duchenne Muscular Dystrophy (DMD) is an X-linked genetic disorder caused by the deletion of the dystrophin gene, leading to defective production of the muscle protein dystrophin, which results in muscle degeneration and atrophy. The only preven...[Read More] Exploring Treatment Options for Duchenne Muscular Dystrophy in Children
Understanding Osteogenesis Imperfecta: Diagnosis, Follow-Up, and Treatment Options
Hello, doctor: What examinations are performed during the initial visit for a patient with Osteogenesis Imperfecta (OI)? What follow-up examinations are conducted afterward? In Taiwan's healthcare system, besides calcium supplements and bisphosphonate medications, are there ...
Dr. Hou Jiawei reply Rare Disease
Osteogenesis Imperfecta (OI), commonly referred to as "glass bone disease," is primarily caused by a hereditary defect in type I collagen, leading to decreased bone strength and increased susceptibility to fractures. Initial evaluations upon first consultation typically...[Read More] Understanding Osteogenesis Imperfecta: Diagnosis, Follow-Up, and Treatment Options
Concerns About Short Stature in Adolescents: Seeking Growth Solutions
Hello Doctor: In January of this year, I took my daughter to Linkou Chang Gung Memorial Hospital for an examination. During the first growth plate X-ray, her height was 143 cm, weight was 31 kg, and there was still 8% growth potential. The doctor advised us not to worry, saying t...
Dr. Xiao Kaiwen reply Pediatrics
Currently, there is not much that the medical community can do for individuals with short stature. Growth hormone is generally most effective for those with growth hormone deficiency-related short stature. Children who do not have growth hormone deficiency may experience accelera...[Read More] Concerns About Short Stature in Adolescents: Seeking Growth Solutions
Related FAQ
Rare Disease Treatment
(Rare Disease)
Osteogenesis Imperfecta(Rare Disease)
Height(Rare Disease)
Congenital Metabolic Disorders(Rare Disease)
Chromosomes(Rare Disease)
Ichthyosis(Rare Disease)
Muscular Diseases(Rare Disease)
G6Pd Deficiency(Rare Disease)
Newborn Screening(Rare Disease)
Tourette Syndrome(Rare Disease)